Merck sues Strides Pharma over HIV treatment

01-12-2016

Merck sues Strides Pharma over HIV treatment

Gil C / Shutterstock.com

Merck has filed a complaint against Strides Pharma for alleged patent infringement over Sustiva (efavirenz), an antiviral medication that prevents HIV from multiplying in the human body.


patent, Merck, Strides Pharma, Sustiva, ANDA, FDA

LSIPR